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Introduction: Obstructive sleep apnea (OSA) has been associated with non-dipping
blood pressure (BP). The precise mechanism is still under investigation, but repetitive
oxygen desaturation and arousal induced sleep fragmentation are considered the
main contributors.
Methods: We analyzed beat-to-beat measurements of hemodynamic parameters (HPs)
during a 25-min period of wake–sleep transition. Differences in the mean HP values for
heart rate (HR), systolic BP (SBP), and stroke volume (SV) during wake and sleep and
their standard deviations (SDs) were compared between 34 controls (C) and 22 OSA
patients. The Student’s t-test for independent samples and the effect size by Cohen’s
d (d) were calculated. HP evolution was investigated by plotting the measured HP
values against each consecutive pulse wave. After a simple regression analysis, the
calculated coefficient beta (SCB) was used to indicate the HP evolution. We furthermore
explored by a hierarchical block regression which variables increased the prediction for
the SCB: model 1 BMI and age, model 2 + apnea/hypopnea index (AHI), and model
3 + arousal index (AI).
Results: Between the two groups, the SBP increased in OSA and decreased in C
resulting in a significant difference (p = 0.001; d = 0.92). The SV demonstrated a similar
development (p = 0.047; d = 0.56). The wake/sleep variation of the HP measured by
the SD was higher in the OSA group—HR: p < 0.001; d = 1.2; SBP: p = 0.001;
d = 0.94; and SV: p = 0.005; d = 0.82. The hierarchical regression analysis of the
SCB demonstrated in SBP that the addition of AI to AHI resulted in 1R2: +0.163 and
1F + 13.257 (p = 0.001) and for SV 1R2: +0.07 and 1F 4.83 (p = 0.003). The AI but
not the AHI remained statistically significant in the regression analysis model 3—SBP:
β = 0.717, p = 0.001; SV: β = 0.469, p = 0.033.
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Conclusion: In this study, we demonstrated that in OSA, the physiological dipping
in SBP and SV decreased, and the variation of all investigated parameters increased.
Hierarchical regression analysis indicates that the addition of the AI to BMI, age, and
AHI increases the prediction of the HP evolution following sleep onset for both SBP and
SV and may be the most important variable.
Keywords: sleep disordered breathing, cardiovascular risk, sleep disturbance, arterial blood pressure, stroke
volume
INTRODUCTION
Sleep and sleep disturbances affect various components of the
human homeostasis including the cardiovascular system (Muller
et al., 1989; Silvani, 2019). In the last decades, the relationship
between obstructive sleep apnea (OSA) and cardiovascular
diseases (CVDs) has been intensively investigated by both basic
science and clinical researchers (Floras, 2018). The assembled
scientific evidence indicates a relevant negative impact of OSA
on several components of the cardiovascular system, including
an increased risk for arterial hypertension (AHT) (Javaheri
et al., 2017). However, the precise mechanism of this interaction
remains unclear, and the effect of OSA therapy on AHT is
inconsistent. Although several longitudinal studies confirmed
OSA as a risk factor for AHT and a benefit from therapy with
continuous positive airway pressure (CPAP) (Peppard et al., 2000;
Marin et al., 2012; Mokhlesi et al., 2014), others were inconclusive
(McEvoy et al., 2016). The importance to use the correct methods
for OSA diagnostic to avoid false-negative results has been
recently underlined (Parati et al., 2019).
Sleep onset is usually accompanied by a physiological
reduction or dipping of the blood pressure (BP) reaching about
10–20% of the values recorded during daytime (Staessen et al.,
1997). A decrease in this physiological BP change is alleged
to induce relevant health consequences due to an increased
risk for CVD (Cuspidi et al., 2018). Compared to the daytime
BP, the nocturnal BP appears more relevant for the prediction
of cardiovascular risk (Fagard et al., 2008; Investigators et al.,
2014). Nocturnal dipping can be reduced, absent, or even
inversed by various internal and external factors including sleep
disorders, obesity, high salt intake, chronic kidney disease,
diabetic neuropathy, and old age (Parati et al., 2014). Although
the presence and extent of dipping is very variable, OSA has
been identified in several studies as a risk factor for non-
dipping BP (Suzuki et al., 1996; Hla et al., 2008; McEvoy et al.,
2016). Recently, the European Society of Cardiology/European
Society of Hypertension considered the suspicion of nocturnal
hypertension in OSA patients an indication for ambulatory
BP measurement (ABPM) rather than home BP measurement
(HBPM) (Williams et al., 2018). However, during the nocturnal
Abbreviations: ABP, arterial blood pressure; ABPM, ambulatory blood pressure
measurement; AHI, apnea/hypopnea index; AHT, arterial hypertension; AI,
arousal index; BP, blood pressure; CVD, cardiovascular disease; d, Cohen’s D or
effect size; HP, hemodynamic parameters; HR, heart rate; MAP, mean arterial
blood pressure; ODI, oxygen desaturation index; OSA, obstructive sleep apnea;
RDI, respiratory disturbance index; SBP, systolic blood pressure; SCB, standardized
correlation coefficient β; SP, sleep period; SRBD, sleep-related breathing disorders;
SV, stroke volume; WP, wake period.
period, the ABPM devices commonly measure the BP in fixed
intervals of 30 min. Thus, the critical change of BP reduction
at the wake/sleep transition is frequently missed. In fact, ABPM
recordings give little detailed information over the night-time
period, since both micro- and macrostructure of the sleep are
not recorded. This is of clinical relevance since respiratory
events during REM sleep are associated with higher BP surges
(Sasaki et al., 2018) and are thought to be especially relevant for
the cardiovascular risk of OSA patients (Mokhlesi et al., 2015;
Mokhlesi and Varga, 2018; Varga and Mokhlesi, 2019). Missing
BP recordings during REM periods due to large intervals might
therefore generate nocturnal BP values that might not reflect
reality. A more detailed measurement of BP values in association
with sleep recordings appears therefore important to objectively
assess the relationship between AHT and OSA.
At present, repetitive oxygen desaturations and activation
of the sympathetic nervous system are considered the main
pathomechanisms in the development of AHT in OSA (Lesske
et al., 1997; Iturriaga et al., 2017). However, AHT is also linked
to other sleep disorders without effect on the arterial oxygen
saturation (Gottlieb et al., 2006; Abbott et al., 2019). A possible
explanation for this is the complex interaction between the
baroreceptor reflex and sleep fragmentation by micro-arousals
(Silvani et al., 2015). Taylor et al. (2016) reported recently
an increase in the daytime sympathetic activity due to sleep
fragmentation that did not depend on the presence of obstructive
apneas/hypopneas.
In this study, we investigated in a detailed beat-to-beat analysis
the influence of either OSAs or sleep fragmentation on the
evolution of hemodynamic parameters (HPs) including heart rate
(HR), systolic BP, and stroke volume (SV).
MATERIALS AND METHODS
Patients
A total of 60 participants were included. All of them
were subsequently admitted to the sleep laboratory for the
investigation of sleep-related breathing disorders. None of
the participants was clinically unstable or referred a relevant
not controlled disease. The use of beta-blockers was an
exclusion criterion, while there was no further restriction
regarding antihypertensive drugs including diuretics, angiotensin
converting enzyme inhibitors, or angiotensin-II receptor blocker.
Four patients were excluded due to major body movement during
the wake/sleep transition, which did not allow enough quality
in the hemodynamic data analysis. The final cohort consisted of
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23 females and 33 males. Likewise, to other studies, OSA was
considered present if the apnea/hypopnea index (AHI) was equal
or higher than 15/h (Martinez-Garcia et al., 2013). Participants
with an increased percentage of central sleep apneas (≥35%) or
periodic leg movement (>15/h) were excluded.
The study was approved by the local Ethical Committee and
informed consent was obtained from all participants.
Polysomnographic Sleep Study
Sleep and sleep-related events were investigated via standard
polysomnography (PSG) by Alice 5 (Koninklijke Philips N.V.
Philips Respironics, Murrysville, PA, United States). The
following parameters were recorded: F3, F4, C3, C4, O1, O2,
M1, and M2. We used the standard referential montage of
scalp electrodes against the contralateral mastoid electrode (e.g.,
C3/M2). Further parameters consisted of submental electrodes,
thermistor and nasal pressure transducer for flow analysis, strain
gauges to record respiratory movements, and EMG at both
legs according to standard PSG procedures. Peripheral oxygen
saturation was analyzed by pulse oximetry. The scoring of sleep
and sleep-related events was based on the recommendation of the
American Academy of Sleep Medicine from 2012 (Berry et al.,
2015). Hypopneas were defined as a 30% decrease in nasal flow
during 10 s with a 4% oxygen desaturation (acceptable hypopnea
criteria according to the manual of American Academy of Sleep
Medicine). This classification results in very high correlation
between the AHI and the oxygen desaturation index (ODI),
which are therefore interchangeable. Also, the respiratory effort
related arousals (RERAs) were scored allowing to distinguish
between hypoxic obstructive respiratory events alone and the
total amount of obstructive respiratory events including the non-
hypoxic one. Additionally, by applying the acceptable hypopnea
classification, the correlation between AI and AHI decreases,
thus allowing the use of both variables independently in the
statistical analysis.
Sleep onset was defined as three subsequent epochs of stable
sleep (in all recordings sleep stage N1 or N2). The 5 min of
wakefulness prior to the first sleep epoch was considered as the
wake period (WP). The following 20 min of sleep after sleep onset
was considered as sleep period (SP).
Measurement of Hemodynamic Parameters
The Nexfin HDTM monitor (BMEYE, Netherlands) has been
developed to investigate non-invasively arterial BP (ABP),
SV, cardiac output (CO), and peripheral vascular resistance
(PVR). The method and its advantage against the non-invasive
ambulatory ABP measurement (ABPM) in fixed intervals have
been previously described (Wesseling, 1996). In short, the arterial
pressure is measured in the finger arteries and consecutively
reconstructed to brachial artery values. This methodology builds
on the volume clamp technique as proposed by Penáz and
the physiological criteria of Wesseling to calibrate the ABP
measurement (Penaz et al., 1976; Wesseling, 1996). CO and
SV are calculated by analyzing the pressure wave via a specific
algorithm (de Jong et al., 2009). Frank and colleagues described
the original concept already in 1899, which was further developed
by Sagawa et al. (1990), Wesseling et al. (1993). This methodology
allows a beat-to-beat analysis of the HPs described above. We
used the heart reference system of the device to minimalize the
impact of postural changes on the HP. In this study, the analyzed
HPs were limited to HR, systolic BP (SBP), and SV.
Statistical Analysis of Hemodynamic Changes During
the Wake/Sleep Transition
Data from the Nexfin-HD device was exported and further
analyzed with the SPSS Statistics software (v.24, IBM Corp.,
Armonk, NY, United States). Values for HR, SBP, and SV were
continuously recorded over the analyzed 25-min period. For each
consecutive pulse wave, the corresponding hemodynamic value
was plotted in a dot blot graphic (Figure 1). A regression analysis
was run with each hemodynamic value as the dependent variable
and the consecutive number of the pulse wave as the independent
variable. This allowed to calculate the scope of the HPs during the
time window with a positive value indicating a rise and a negative
value a decrease in either HR, BP, or SV. For further statistical
analysis of the hemodynamic evolution at sleep onset, we utilized
the standardized coefficient β (SCB).
Differences of the hemodynamic variables between wake
and sleep were computed by subtraction of the average value
during the WP from the average value after falling asleep.
To analyze the short-term variance of the HPs, the standard
deviation (SD) of each HP during sleep was subtracted from the
corresponding value during wakefulness. After controlling for
the normal distribution with the Shapiro–Wilk’s test (p > 0.05),
the statistical significance between the control and the OSA
group was calculated by the Student’s t-test for independent
samples and the change of wake–sleep transition by the paired
sample Student’s t-test. In case of a non-normal distribution
of a variable, we applied the non-parametric Mann–Whitney
U-test for independent samples or the related samples Wilcoxon
signed-rank test, respectively.
A receiver operator characteristic (ROC) analysis was
computed to investigate if the SBP values during wakefulness
(WP) and sleep (SP) and the mean difference between the two
periods can discriminate between the presence or absence of OSA
(AHI> 15/h) or sleep fragmentation [arousal index (AI)> 15/h].
Additionally, a simple linear regression analysis was run
between the consecutive heart beats or better pulse waves as the
independent variable and each corresponding HP as dependent
variables. The SCB was calculated and used to analyze the
development of the HP during the observation period. A negative
SCB is equivalent to a decrease in the investigated parameter, while
a positive result indicates an increase during the SP (Figure 1).
Furthermore, a hierarchical block multiple linear regression
analysis was applied to explore the impact of age, BMI,
AHI, and AI during the investigated wake/sleep period, on
the linear development of the HPs (increase or decrease)
characterized by the SCB.
Sleep efficiency was not included since we found no significant
impact on any of the investigated HPs in the initial simple
regression analysis (Table 4). Model 1 consisted of age and BMI,
model 2 added the AHI, and model 3 added the AI to model
2 variables. We choose to add sleep fragmentation after the
AHI to investigate a possible increase in the prediction of the
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FIGURE 1 | Simple dot blot of each measured pulse wave against the corresponding systolic blood pressure (SBP). The regression line indicates the general
direction of the SBP during the observed time period. Arousal index (AI), apnea/hypopnea index, and the calculated standardized coefficient β (SCB) of each
demonstrated example are indicated. In controls we found mainly a negative SCB indicating a decrease in the SBP (A) while patients with OSA tended to increase
the SCB (C,D). However, an increase in the SBP was also detected in the absence of a significant OSA (AHI > 15/h) if sleep fragmentation was present (B). In some
OSA patients, the SCB kept stable and only the variance of the SBP increased (E).
hemodynamic values. As stated above, the AHI and ODI were
highly correlated and thus only AHI was used in this model.
A binominal logistic regression model was performed to test
the prediction quality of a model including age, BMI, and AI for
a non-dipping of the HP values at sleep onset. Non-dipping was
classified as a SCB≥ 0 for all three HP variables. A ROC curve was
plotted to calculate the overall measure of discrimination [area
under the curve (AUC)].
RESULTS
We found in 22 participants an AHI ≥ 15 (OSA) and in 34 an
AHI < 15/h (controls). Anthropometric and polysomnographic
values are listed in Table 1. Between controls and OSA, we found
no statistically significant difference in either age or body mass
index (BMI) (p > 0.05). Sleep efficiency, percentage of slow wave
sleep (N3), and mean peripheral oxygen saturation (SpO2) were
significantly higher in controls (both p < 0.05), while the AI, the
AHI, and the ODI were significantly increased in the OSA group
(all p < 0.001). There was no statistically significant difference in
the percentage of oxygen saturation under 90% (T90) (p > 0.05).
Also, no statistically significant gender difference was detected for
either AHI or ODI (p> 0.05). Within the total study population,
we found both AHI and ODI highly correlated (r = 0.90;
p < 0.001). Also, for AI versus AHI (r = 0.80; p < 0.001) or
AI versus ODI (r = 0.74; p < 0.001), a positive correlation was
detected, although to a lower agreement compared to AHI/ODI.
Thus, all three parameters were correlated with each other, but
AHI and ODI could be considered almost interchangeable.
During the wake-to-sleep transition, almost all HPs changed
significantly. The major results are listed in Table 2. Besides
indicating significant results with an alpha level of 0.05, we
also calculated the effect size (Cohen’s d) to increase the
visibility of possible relevant outcomes. Controls HR and SBP
decreased significantly from wakefulness to sleep, but not SV.
Contrary to this result, in the OSA group, sleep onset was
not associated with any significant change in HP. In both
wakefulness and sleep, we detected a significantly higher HR
in the OSA group. Interestingly, during wakefulness, neither
the SBP nor the SV differed between the two groups. The
wake–sleep transition revealed in both groups a significant
change for SBP and SV. While in controls both parameters
decreased, the evolution was inverse in OSA patients. The
effect size of this divergent HP development was high for SBP
(d = 0.92) and moderate for SV (d = 0.56). Thus, only during
sleep a highly relevant difference could be seen. Contrary to
this, we did not find significant results for HR (p = 0.49),
Frontiers in Physiology | www.frontiersin.org 4 March 2020 | Volume 11 | Article 104
fphys-11-00104 March 11, 2020 Time: 20:37 # 5
Staats et al. Sleep Fragmentation and Hemodynamic Dipping
TA
B
LE
1
|A
nt
hr
op
om
et
ric
an
d
po
ly
so
m
no
gr
ap
hi
c
da
ta
.
A
g
e
[y
ea
rs
]
B
M
I[
kg
/m
2
]
S
le
ep
-E
[%
]
N
1/
N
2
[%
]
N
3
[%
]
A
I[
/h
]
A
H
I[
/h
]
O
D
I[
/h
]
M
ea
n
S
p
O
2
T
90
[%
]
C
on
tr
ol
s
n:
34
44
.9
1
(±
10
.0
)
36
.7
5
(±
9.
46
)
72
.6
(±
17
.6
)*
87
.5
3
(±
19
.4
6)
*
12
.4
6
(±
19
.4
6)
*
21
.5
1
(±
20
.5
6)
**
3.
08
(±
5.
06
)*
*
5.
76
(±
14
.3
0)
**
94
.8
5
(±
1.
91
)*
1.
65
(±
6.
29
)
O
S
A
n:
22
50
.4
1
(±
10
.0
)
40
.9
2
(±
8.
18
)
62
.4
8
(±
13
.0
6)
98
.1
9
(±
6.
38
)
1.
80
(±
6.
38
)
75
.0
6
(±
36
.8
2)
66
.0
(3
2.
67
)
76
.3
5
(±
34
.0
4)
93
.0
9
(±
2.
78
)
11
.7
8
(2
2.
54
)
M
ea
n
va
lu
es
(±
st
an
da
rd
de
vi
at
io
n)
of
th
e
an
th
ro
po
m
et
ric
an
d
po
ly
so
m
no
gr
ap
hi
c
da
ta
.
S
ig
ni
fic
an
t
re
su
lts
(p
<
0.
05
)
ar
e
in
di
ca
te
d
by
si
m
pl
e
*
an
d
hi
gh
ly
si
gn
ifi
ca
nt
re
su
lts
(p
<
0.
00
1)
w
ith
a
do
ub
le
**
.
Th
er
e
w
as
no
st
at
is
tic
al
ly
si
gn
ifi
ca
nt
di
ffe
re
nc
e
in
ag
e,
B
M
I,
an
d
T
90
.
B
M
I,
bo
dy
m
as
s
in
de
x;
S
le
ep
-E
,
sl
ee
p
ef
fic
ie
nc
y;
N
1,
N
2
sl
ee
p
st
ag
e
N
Io
r
N
2
or
lig
ht
sl
ee
p;
N
3,
sl
ee
p
st
ag
e
N
III
,
sl
ow
w
av
e
sl
ee
p;
A
I,
ar
ou
sa
li
nd
ex
;
A
H
I,
ap
ne
a/
hy
po
pn
ea
in
de
x;
O
D
I,
ox
yg
en
de
sa
tu
ra
tio
n
in
de
x;
S
pO
2
,p
er
ip
he
ra
ls
at
ur
at
io
n
of
ox
yg
en
;T
90
,p
er
ce
nt
ag
e
of
S
pO
2
<
90
%
.
TABLE 2 | Student’s t-test and Cohen’s d: Hemodynamic parameters and its
variation during wakefulness and sleep in controls and OSA patients.
Controls (SD)
(n = 34)
OSA (SD)
(n = 22)
1 Controls-
OSAS (SD)
significance;
effect size
HR wake [/min] 67.51 (10.60) 76.93 (13.12) −9.42 (−2.52)
p = 0.005;
d = 0.79
HR sleep [/min] 66.21 (11.11) 76.22 (12.01) −10.01 (−0.90)
P = 0.002;
d = 0.86
1 HR wake–sleep
[/min] (SD);
significance; effect
size
1.30 (2.97);
p = 0.016);
d = 0.11
0.71 (3.27)
p = 0.32;
d = 0.07
0.59 (−0.30)
p = 0.49,
d = 0.19
SBP wake [mmHg] 116.82 (14.84) 123.51 (19.35) −6.69 (−4.51)
p = 0.150;
d = 0.39
SBP sleep [mmHg] 113.09 (15.40) 126.78 (18.80) −13.69 (−3.4)
p = 0.004;
d = 0.80
1 SBP wake–sleep
[mmHg] (SD);
significance, effect
size
3.74 (7.50);
p = 0.007;
d = 0.25
−3.26 (7.62)
p = 0.058);
d = 0.02
7.0 (−0.12)
p = 0.001;
d = 0.92
SV wake [ml] 100.23 (14.41) 99.20 (25.67) 1.03 (−11.26)
p = 0.85; d = 0
0.05
SV sleep [ml] 98.86 (14.65) 100.75 (24.38) −1.89 (−9.73)
p = 0.72;
d = 0.09
1 SV wake–sleep
[ml] (SD);
significance, effect
size
1.37 (5.52)
p = 0.158;
d = 0.09
−1.55 (4.78)
p = 0.14;
d = 0.06
2.92 (0.74)
p = 0.047;
d = 0.56
HR SD wake [/min] 6.40 (3.69) 5.97 (3.80) 0.43 (−0.11)
p = 0.681;
d = 0.11
HR SD sleep [/min] 4.69 (2.05) 7.27 (3.59) −2.58 (−1.54)
p < 0,001;
d = 0.88
1 HR SD
wake–sleep [/min]
(SD); significance;
effect size
1.70 (3.07)
p = 0.003;
d = 0.57
−1.75 (2.67)
p = 0.006;
d = 0.35
3.45 (0.4)
p < 0,001;
d = 1.20
SBP SD wake
[mmHg]
8.20 (3.26) 9.04 (2.63) −0.83 (0.63)
p = 0.32;
d = 0.28
SBP SD sleep
[mmHg]
7.83 (2.35) 11.73 (3.48) −3.90 (1.13)
p < 0.001;
d = 1.31
1 SBP wake–sleep
[mmHg] (SD);
significance; effect
size
0.373 (2.89)
p = 0.46);
d = 0.13
−2.69 (3.51)
p = 0.002;
d = 0.87
3.06 (−1.86)
p = 0.001;
d = 0.94
SV SD wake [ml] 8.62 (4.54) 13.97 (21.53) −5.35 (−16.99)
p = 0.16;
d = 0.34
SV SD sleep [ml] 7.04 (2.77) 15.32 (21.61) −15.28
(−18.84)
p = 0.03;
d = 0.54
(Continued)
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TABLE 2 | Continued
Controls (SD)
(n = 34)
OSA (SD)
(n = 22)
1 Controls-
OSAS (SD)
significance;
effect size
1 SV wake–sleep
SD [ml] (SD);
significance, effect
size
1.58 (3.92)
p = 0.025;
d = 0.42
−1.34 (3.15)
p = 0.058;
d = 0.06
2.92 (0.77)
p = 0.005;
d = 0.82
Average (±standard deviation) of the hemodynamic values and the mean standard
deviation (SD) in controls and OSA patients during wakefulness (wake) and sleep.
Significance values and the effect size (Cohen’s d) were calculated between
wakefulness and sleep for each group and between controls and OSA. 1,
difference (either wake/sleep or controls/OSA); SD, standard deviation; d, Cohen’s
d; HR, heart rate; SBP, systolic blood pressure; SV, stroke volume.
and the effect size between the two groups was very small
(d = 0.19).
The assessment of the HP variability was performed by
analyzing SDs of the mean values during wakefulness and sleep.
In controls, sleep onset was not accompanied by any significant
change in the SBP variance (p > 0.05). Contrary to this, we
observed a significant decrease in the SD of HR and SV (p = 0.003
and 0.025, respectively) with a moderate effect size (d = 0.57 and
0.42, respectively). This reflects the physiological stabilization of
the HP during sleep. In the OSA group, SD increased significantly
in both HR and SBP (p = 0.006 and p = 0.002, respectively)
but not in SV (p = 0.058). The effect size was very small for
SV (d = 0.06), small to moderate for HR (d = 0.35), and high
in SBP (d = 0.87). In the comparison of changes in the HP
during sleep onset, statistically significant results were detected
for all three HPs. The calculated effect size was huge for the
HR exceeding one SD (d = 1.20) and large for SBP (d = 0.94)
and SV (d = 0.82). Therefore, analyzing each group isolated,
sleep onset caused only a mild to moderate change in the HP.
However, since the direction was opposed (decrease in controls
and increase in OSA), we found highly significant results when
comparing the two groups.
To further investigate the relationship between OSA and
HP during sleep, we run a receiver operator curve (ROC)
analysis. SBP values discriminated between the presence and
absence of OSA during sleep with an AUC of 0.745 (95%
CI, 0.616–0.873; p < 0.001) with an overall model accuracy
of 0.62. However, during wakefulness, the AUC for the SBP
value was 0.596 (95% CI, 0.442–0.751), and the result did
not reach statistical significance (p = 0.222). Since SBP during
sleep revealed a discriminative capability for OSA versus
non-OSA, we furthermore investigated the relevance of the
change in SBP values (wake SBP values minus sleep SBV
values). The AUC was 0.74 (95% CI, 0.61–0.87), indicating
an acceptable discrimination. The result reached statistical
significance (p < 0.001) with an overall model quality of 0.61.
When the same analysis was run for the presence of sleep
fragmentation defined as an AI > 15/h, the AUC for the SBP
during sleep was 0.79 (95% CI, 0.64–0.94). On the other hand,
during wakefulness, the result was not significant. The AUC for
the wake–sleep difference of the SBP was 0.79 (95% CI 0.67–0.91;
p < 0.001) and therefore good discrimination with an overall
model accuracy of 0.67. The paired sample of the wake–sleep area
difference under the ROC curves of the SBP reached a z score
of −3.17 with an AUC difference of −0.154 (CI, −2.49 – 0.59),
which reached statistical significance (p = 0.002). These results
indicate that SBP values and the change of the SBP in the first
20 min of sleep discriminate between the presence or absence of
OSA. This was even more evident for the presence or absence of
sleep fragmentation.
Each measured pulse wave was plotted beat-to-beat against
the value of the investigated HP (Figure 1). As described in
the “Materials and Methods” section, the SCB was calculated
to assess the continuous evaluation of the HPs during the
investigated period. Controls demonstrated a negative SCB and
thus a reduction in all HPs (Table 3 and Figure 1A). The effect
was more visible in the SBP values compared to HR or SV. In
the OSA group, the decline of the BP values was attenuated or
inverted, although this was also visible in patients with sleep
fragmentation without significant OSA (Figure 1B). These results
reached statistical significance for SBP (p = 0.031) with a small
to moderate effect size (d = 0.32) and SV (p = 0.033) with a
medium effect size (d = 0.62). Results are listed in Table 3. It is of
interest that we found considerable variation of the HP changes
at sleep onset even in individuals with severe OSA. In Figure 1C,
wake–sleep transition is accompanied by an increase in the SBP
but almost without any change in variability. The participant in
Figure 1D reveals an increase in both SBP and its variability. In
Figure 1E, only SBP variability increases while SCB indicates a
small decrease in SBP.
To investigate the effect of anthropometric and sleep variables
on the progression of the HPs, we performed a simple regression
analysis with HR, SBP, and SV as dependent variables and age,
BMI, AHI, AI, and sleep efficiency (Sleep-E) as independent
variables. The main results are illustrated in Table 4. Sleep-E
was ruled out for further analysis since no significant result was
detected. Age reached statistical significance for HR and just
exceeded the alpha level for SBP (p = 0.073). BMI did not reach
statistical significance for any of the three investigated HPs, but
due to its correlation with the AHI (r:0.256; p = 0.057), it was
kept for further analysis.
A hierarchical multiple regression analysis was run to
investigate if prediction of hemodynamic development measured
by the SCB was improved by adding to age and weight (model 1)
TABLE 3 | Standardized coefficient β of consecutive pulse waves versus
hemodynamic parameter.
Controls n: 34
Average (±SD)
OSA n:22
Average (±SD)
P-value d
HR SCB −0.01 (0.28) −0.06 (0.23) 0.483 0.19
SBP SCB −0.16 (0.38±) 0.05 (±0.29) 0.031 0.32
SV SCB −0.07 (±0.29) 0.09 (0.22) 0.033 0.62
Average (standard deviation) of the standardized coefficient β (SCB), which was
calculated by regression analysis of the measured hemodynamic value against
each consecutive pulse wave. Controls demonstrated a negative SCB and thus
decline of heart rate (HR), systolic blood pressure (SBP), and stroke volume (SV)
during the 25-min period. In the OSA group, this decrease was attenuated or in
case of stroke volume even inverted. The detected significance values and the
effect size (d = Cohen’s d) are listed in the last two columns.
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TABLE 4 | Simple regression analysis of anthropometric and sleep variables on the standardized coefficient β (SCB) of the hemodynamic parameters.
SCB HR SCB SBP SCB SV
B (CI 95) β P B (CI 95) β P B (CI 95) β P
Age [years] −0.007 (−0.014 to 0.000)* −0.268 0.046 0.008 (−0.001 to 0.018) 0.242 n.s. 0.002 (−0.006 to 0.009) 0.07 n.s.
BMI [kg/m2] −0.001 (−0.008 to 0.008) −0.021 n.s. −0.005 (−0.016 to 0.005) −0.147 n.s. −0.005 (−0.013 to 0.003) 0.162 n.s.
AHI [/h) −0.001 (−0.003 to 0.001) −0.194 n.s. 0.003 (0.00 to 0.005) 0.296 0.027 0.003 (0.001–0.005) 0.347 0.005
AI [/h) −0.001 (−0.003 to 0.001) −0.106 n.s. 0.004 (0.002 to 0.007) 0.476 0.007 0.003 (0.002 to 0.005) 0.451 <0.001
Sleep-E [%] 0.001 (−0.003 to 0.005) 0.064 n.s. −0.002 (−0.008 to 0.004) −0.079 n.s. 0.000 (−0.004 to 0.005) 0.023 n.s.
Simple correlation body mass index (BMI); apnea/hypopnea index (AHI), arousal index (AI), and sleep efficiency (Sleep-E) with standardized coefficient β (SCB) of
heart rate (HR), systolic blood pressure (SBP), and stroke volume (SV). The p-values for the statistically significant results are displayed in the third column of each
hemodynamic parameter. Age negatively correlated with the HR evolution, but statistical significance was low. Both AHI and AI were positively correlated with an increase
in the SBP and SV.
TABLE 5 | Hierarchical regression analysis of anthropometric and sleep variables for the hemodynamic standardized coefficient β prediction of heart rate.
Standardized coefficient β (SCB) of Heart Rate (HR)
Variable Model 1 Model 2 Model 3
B (95% CI) β B (95% CI) β B (95% CI) β
Constant 0.237 (−0.143 to 0.617) 0.202 (−0.081 to 0.585) 0.166 (−0.239 to 0.571)
Age −0.008 (−0.015 to 0.000) −0.271 −0.007 (−0.014 to 0.00) −0.271 −0.007 (−0.014 to 0.001) 0.264
BMI 0.002 (0.006 to 0.011) 0.083 −0.001 (−0.005 to 0.00) 0.115 0.004 (−0.005 to 0.012) 0.124
AHI −0.001 (−0.003 to 0.001) −0.162 −0.002 (−0.005 to 0.001) 0.138
AI 0.001 (−0.002 to 0.004) 0.138
Model 1 Model 2 Model 3
R2 0.078 0.319 0.328
F 2.236 (n.s.) 1.962 (n.s.) 1.54 (n.s.)
1R2 0.024 0.006
1F 1.383 (n.s.) 0.348 (n.s.)
Hierarchical regression analysis of the SCB from heart rate. None of the models reached statistical significance. BMI, body mass index; AHI, apnea/hypopnea index; AI,
arousal index; Sleep-E, sleep efficiency.
TABLE 6 | Hierarchical regression analysis of anthropometric and sleep variables for the hemodynamic standardized coefficient β prediction of systolic blood pressure.
Standardized coefficient β (SCB) of Systolic Blood Pressure (SBP)
Variable Model 1 Model 2 Model 3
B (95% CI) β B (95% CI) β B (95% CI) β
Constant −0.229 (−0.737 to 0.280) −0.136 (−0.628 to 0.357) −0.392 (−0.857 to 0.073)
Age 0.012 (0.002 to 0.021) * 0.334 0.010 (0.001-0.019 0.284 0.011 (0.003 to 0.020) * 0.321
BMI −0.010 (−0.021 to 0.000) −0.264 −0.013 (−0.024 to −0.002) * −0.327 −0.011 (−0.021 to −0.001) * −0.279
AHI 0.003 (0.001 to 0.006) * 0.314 −0.003 (−0.007 to 0.001) −0.295
AI 0.007 (0.003 to 0.010) * 0.717
Model 1 Model 2 Model 3
R2 0.345 0.458 0.373
F 3.59 (p = 0.034) 4,595 (p = 0.006) 7.572 (p < 0.001)
1R2 0.09 0.163
1F 5.935 (p = 0.018) 13.257 (p = 0.001)
Hierarchical regression analysis of the SCB of systolic blood pressure. In model 1 age reached statistical significance (p = 0.019). In model 2 age (p = 0.038), BMI
(p = 0.018), and AHI (p = 0.018) were statistically significant. There was a significant change compared to model 1. In model 3, age (p = 0.010), BMI (p = 0.026), and
arousal index (p = 0.001) were statistically significant. R2 F(1.51) increased significantly from model 2 to model 3. *p < 0.05.
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TABLE 7 | Hierarchical regression analysis of anthropometric and sleep variables for the hemodynamic standardized coefficient β prediction of stroke volume.
Standardized coefficient β (SCB) of Stroke Volume (SV)
Variable Model 1 Model 2 Model 3
B (95% CI) β B (95% CI) β B (95% CI) β
Constant 0.58 (−0.352 to 0.469) 0.151 (−0.235 to 0.536) 0.021 (−0.37 to 0.412)
Age 0.004 (−0.004 to 0.012) 0.144 0.002 (−0.005 to 0.010) 0.081 0.003 (−0.004 to 0.01) 0.105
BMI −0.007 (−0.015 to 0.002) −0.213 −0.009 (−0.017 to −0.001) * −0.294 −0.008 (−0.016 to 0.00) −0.263
AHI 0.003 (0.001 to 0.005) * 0.404 0.0004 (−0.003 to 0.003) 0.005
AI 0.003 (0.00 to 0.007) * 0.469
Model 1 Model 2 Model 3
R2 0.045 0.194 0.263
F 1.240 (n.s.) 4.161 (p = 0.01) 4.558 (p = 0.003)
1R2 0.149 0.07
1F 9.599 (p = 0.003) 4.83 (p = 0.033)
Hierarchical regression analysis of the SCB of stroke volume. Both BMI and AHI reached statistical significance in model 2 (p = 0.035 and p = 0.003, respectively). R2
F(1.52) changed significantly when compared to model 1. In model 3, only the arousal index remained statistically significant (p = 0.033), and we found a significant
increase in R2 F(1,51) when compared to model 2. *p < 0.05.
the AHI (model 2) and the AI (model 3). There was independence
of residuals with the Durbin–Watson statistic of 2.337 for HR,
2.00 for SBP, and 1.60 for SV, respectively. Multicollinearity
was ruled out as assessed by tolerance values above 0.2 (with a
minimum of 0.297 for AHI).
For HR, none of the models increased significantly the
prediction of the SCB. When analyzing the SCB of SBP, all
three models reached statistical significance in the regression
ANOVA analysis. However, the full model 3 of age, BMI, AHI,
and AI eventually was the most robust one with R2 = 0.373;
F(4.51) = 7.572, p < 0.001; adjusted R2 = 0.323. The addition of
the AI to the prediction model 2 (age, BMI, and AHI) resulted
in a significant increase in R2 by 0.163 and F(1.51) of 13.257
(p = 0.001). For SV, we found models 2 and 3 reaching statistical
significance. For model 2 with an R2 = 0.194; F(3.52) = 4.16,
p = 0.01; adjusted R2 = 0.147, the R2 increased 0.149; F(1/52)
9.599. In model 3, R2 reached a value of 0.206; F(4.51) 4.56,
p = 0.003 and adjusted R2 = 0.206. R2 increased by 0.07 with
F(1.51) 4.83, p = 0.033. Thus, the impact of the AI on the SCB
of the SV was less clear compared to the results seen for SBP. The
main results are listed in Tables 5–7.
To confirm our assumption that AHI and ODI are
interchangeable in this analysis, we recalculated model 3 with
either the respiratory disturbance index (RDI) or ODI instead of
AHI. As shown in Supplementary Table 1, in both cases, only the
AI was significant.
Furthermore, a binominal logistic regression analysis was run
to investigate the capability of a model with age, BMI, AHI, and
AI to predict non-dipping of HP, defined as SCB ≥ 0. We found
no statistically significant results for HR. Non-dipping in SBP was
detected in 46% of the study population and therefore higher than
the overall percentage of OSA patients (39.28%). The regression
model was statistically significant [χ2(4) = 29.91; p < 0.001;
Nagelkerke R2 = 0.54]. All four parameters reached significant
results with lower values for BMI (B = −0.103, SE = 0.52;
p = 0.045) and AHI (B = −0.048, SE = 0.02; P = 0.03) and higher
for age (B = 0.170, SE = 0.05; p = 0.001) and AI (B = 0.042;
SE = 0.02; p = 0.010). The odds ratio was 1.19 (95% CI: 1.07–1.31)
for age, 0.90 for BMI (95% CI: 0.81–1.00), 1.073 for AI (95% CI:
1.02–1.12), and 0.95 for AHI (95% CI: 0.91–0.99), respectively.
The overall correct prediction for the non-dipping of SBP was
78.6% with a sensitivity to identify non-dipper of 76.9% and a
specificity of 80%. The positive predictive value was 66.7% with
a negative predictive value of 76.9%. The ROC curve for the
total model demonstrated an excellent AUC of 0.88 (95% CI:
0.78–0.97). When running the analysis only with the AI, the
AUC reached a value of 0.72 (95% CI: 0.59–0.86), which can be
considered an acceptable discrimination (Figure 2).
Regarding SV, we that found that, in 51.8% of the total
population, the SCB of SV was equal to or superior to 0,
indicating non-dipping. The regression model for non-dipping
in SV reached statistical significance [χ2(4) = 11.19; p < 0.025,
Nagelkerke R2 = 0.242]. However, only the BMI was a statistically
significant (p = 0.048) predictor in the model.
DISCUSSION
In this study, we investigated the impact of OSA on the HPs
during the wake–sleep transition. Conventionally, changes of
BP from wake to sleep are investigated comparing the averages
of selected periods within each state. We used this method
to confirm our study protocol, but our main objective was to
evaluate the impact of respiratory events and sleep fragmentation
on the evolution of the recorded HP at sleep onset. This approach
allows a more precise knowledge of short-term hemodynamic
consequences of OSA at sleep onset and the effect of sleep
disruption by respiratory events. As a major finding, we could
detect that sleep fragmentation by arousals correlated better with
the SBP evolution at sleep onset than the AHI.
Khatri and Freis. (1967) were one of the early groups to
describe a decrease in ABP at sleep onset and a reduction in the
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FIGURE 2 | ROC curve of the arousal index to separate dipping and
non-dipping systolic blood pressure (SBP). There was an acceptable
discrimination by the AUC of 0.72 (95%CI: 0.59–0.86), which indicates that
sleep fragmentation can be used to identify patients with non-dipping blood
pressure and therefore cardiovascular risk.
CO due to a decreased HR. However, in this study, ABP was
investigated by an intra-arterial catheter. Due to its invasiveness,
this method has been, in general, replaced by a beat-to-beat
measurement via the volume clamp methodology (Marrone and
Bonsignore, 2018). We used the Nexfin-HD monitor in this
study, which has been thoroughly investigated in several clinical
settings (Fischer et al., 2012; Bubenek-Turconi et al., 2013;
Pouwels et al., 2017).
When compared to the study of Khatri and Freis. (1967), our
control group demonstrated a similar development of the HP.
The averages between wake and sleep period demonstrated a
significant decrease in HR, while the SV remained unchanged.
The reduction in the SBP has been previously described by other
groups and is linked to a reduction in the sympathetic-nerve
activity (Somers et al., 1993). It is notable, that in our control
group neither HR nor SBP reached the described reduction
between 10 to 20% compared to wakefulness indicated by several
authors (Silvani and Dampney, 2013 #4419; Cuspidi et al., 2018
#4505) including a joint recommendation of the International
Society for Chronobiology (ISC), American Association of
Medical Chronobiology and Chronotherapeutics (AAMCC),
Spanish Society of Applied Chronobiology, Chronotherapy,
and Vascular Risk (SECAC), Spanish Society of Atherosclerosis
(SEA), and Romanian Society of Internal Medicine (RSIM)
(International Society for Chronobiology et al., 2013 #4522).
However, in Khatri’s study, the mean arterial pressure also
reached a maximum reduction of only 8.5% when analyzed
during slow-wave sleep (Khatri and Freis., 1967). Positional
changes of the arm might be considered a risk factor for
unreliable ABP measurement by the volume-clamp method.
Leroy and colleagues found in a study with a Finapres volume-
clamp device that, in fact, hand movements had little relevance
on the final ABP results (Leroy et al., 1996). The more modern
Nexfin-HD monitor automatically smoothens the impact of
hydrostatic variation in the ABP pressure due to positional
changes by means of an integrated heart reference system.
Nevertheless, we excluded four participants due to large body
movements and therefore a decrease in the reliability of the ABP
measurement. The measured HP averages in our control group
at wake–sleep transition are in accordance with other studies
supporting the adequacy of our method.
A blunted hemodynamic response to sleep onset is considered
a risk factor for CVDs (Hermida et al., 2013). We could show that
no significant wake–sleep variation of HR, SBP, or SV occurred
in the OSA group. The relevance of OSA for the existence of
non-dipping ABP was recently described in the Wisconsin Sleep
Cohort Study. Mokhlesi et al. (2015) found in OSA patients an
increased risk of 2.84 (95% CI 1.10–7.29) for non-dipping ABP in
REM sleep when compared to the control group. Our study was
not designed to evaluate the overall dipping of the hemodynamic
values during sleep. Nevertheless, it might be of interest that the
detected effect size of OSA was moderate in case of the SV and
large for SBP. These results support therefore the observation that
the presence of OSA has an important impact on the non-dipping
of HP during sleep. In this study, the ROC curve analysis revealed
that SBP values during sleep and the wake–sleep difference of the
mean SBP had acceptable discriminating capability to identify
OSA patients. However, SBP was an even better discriminator
for the presence of sleep fragmentation even at a relatively low
value of 15 arousals/h of sleep. A missing reduction of the SBP is
associated with an increase in the total cardiovascular risk (Seif
et al., 2014) and can cause preclinical cardiac damage (Cuspidi
et al., 2018). Therefore, our study underlines the importance to
diagnose OSA in an early state of the disease to avoid possible
cardiovascular side effects, which can be prevented by adequate
therapy (Sapina-Beltran et al., 2019).
An increased ABP variability is considered a risk for target
organ damage (Stamatelopoulos et al., 2010). In an early study,
Leroy et al. (1996) demonstrated a higher ABP variation in OSA
patients when compared to controls. Narkiewicz et al. (1998)
reproduced this result even during wakefulness. In our study
population, ABP variation during wakefulness did not differ
statistically significantly between the two investigated groups.
Contrary to this, with sleep onset, the variation of all HP values
decreased in the control group, while OSA patients manifested
the opposite reaction. Besides reaching statistical significance, the
calculated effect size between the two groups was either large (SV)
or very large (HR and SBP) confirming the relevance of this result.
It is difficult to compare the results between beat-to-beat and
ambulatory BP measurements (ABPMs). Evidence indicates that
besides the increased short-term BP variability, the midterm
ABP variability investigated by ABPM is also increased in OSA
(Martynowicz et al., 2016). Ke et al. (2017) associated OSA-
related enhanced SBP variability in ABPM recordings with
an increased risk of CVDs. In our study, the short-term HP
variability was the most significant difference between controls
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and OSA patients. Indeed, in some OSA patients, the HP
variability was the only value that changed following sleep onset.
It can be concluded that OSA has, at least during sleep, a negative
impact on the variation of HP. Nevertheless, a cause–effect
relationship regarding CVDs needs to be further established.
To our knowledge, we are the first to investigate the influence
of sleep on the HP progress by the SCB. The advantage of this
method is that a successive evolution of the HP is investigated
and not only a selected representative episode. Hence, the
physiological progress of the HP at sleep onset is better reflected,
and short periods of wakefulness or body movement have, if at all,
only little influence on the results. The SCB mirrored the results
detected from the sleep/wake period analysis. Controls displayed
negative SCB values corresponding to the physiological decrease
of HP during sleep. The OSA group exhibited an attenuation of
the SCB value for SBP and reached a positive value for the SV.
This reflects the impact of OSAs on the two HPs. The HR was, in
agreement with the previously discussed results, not significantly
different between the two groups.
Interestingly, both the simple and the hierarchical regression
analyses revealed for sleep fragmentation a higher relevance
concerning the ABP evolution than the AHI itself. The impact
of arousals on ABP changes has been intensively investigated
in previous studies. Already Somers et al. (1995) showed that
OSA-induced arousals caused significant changes in the ABP.
Morgan et al. (1996) found that cortical arousals induced by
auditory stimuli induces a cardiovascular response leading to
an increase in the ABP and HR and a decrease in the CO.
Several other forms of arousals without relevant flow limitation
and/or oxygen desaturations can induce transitory ABP swings
(Ali et al., 1991; Davies et al., 1993; Lofaso et al., 1998).
Thus, the stimulation of the central nervous system visible
as acceleration in the EEG frequency induces a direct and
instantaneous reaction of the cardiovascular system. Ringler et al.
(1990) described that the mean arterial BP (MAP) reacted equally
to hypoxic apneas as to apneas without desaturations due to
oxygen supplementation. Also, acoustic arousals triggered the
same hemodynamic response as hypoxic apneas, while chronic
hypoxia at 80% did not induce any change in the MAP (Ringler
et al., 1990). At present, it is still under discussion if arousals
without respiratory events especially without relevant change
in the oxygen tension can provoke a longer lasting increase
in the SBP. Morrell et al. (2000) described in a cross-sectional
analysis of the Wisconsin Sleep Cohort study that non-apneic
participants with increased sleep fragmentation index revealed
an elevated ABP when compared to controls. Stradling et al.
(2000) investigated if sleep variables could predict the evening
and morning ABP difference. In this study, only the ODI and the
respiratory effort demonstrated a relevant independent impact
on the decrease in the evening/morning ABP difference. ABP
arousals measured by the pulse transient time (PTT) did not
reach statistical significance, while the respiratory effort and
ODI together explained 7–10% of the ABP variation (Stradling
et al., 2000). We investigated the SCB of the HP instead of
the evening/morning difference over a shorter time period but
with continuous measurement. Nevertheless, model 2 of the
hierarchical regression analysis including age, BMI, and AHI
accounted for 21% variation of the systolic ABP SCB variation.
By addition of the AI, we found a significant increase in the
predictive value of the model to 37.3% (Table 6). In accordance
to our results, Carrington and colleagues could show that artificial
sleep fragmentation during 20 min after sleep onset reduced the
physiological ABP decrease (Carrington and Trinder, 2008). In
another study, Taylor et al. (2016) investigated the impact of
several sleep parameters on the daytime sympathetic activity.
They found that the sympathetic discharges correlated best with
the AI followed by the ODI and discussed if sleep fragmentation
by any cause could increase the probability of cardiovascular
events (Taylor et al., 2016). Noda et al. (2000) detected in an
ABPM study that movement arousals were the most important
factor for elevated 24-h ABP values followed by the ODI. It is of
importance that our study was designed to use the AHI practically
interchangeable with the ODI. We controlled this assumption
by using the ODI instead of the AHI in the statistical analyses
and found an identical outcome. Taken alone, the AHI increases
significantly the predictive value compared to age and BMI alone.
Only when the AI was joined in the model 3 AHI lost its relevance
in the regression model (Table 6). Sleep fragmentation due to
increased respiratory effort seems unlikely to explain this result,
since the substitution of RDI instead of AHI did not reveal a
different result.
The relationship between SBP and sleep fragmentation was
also confirmed in the ROC analysis of the SBP during the wake
and sleep period. The mean SBP values during the SP and the
difference of the mean SBP during the wake and sleep period
demonstrated a good discrimination accuracy for the presence of
sleep fragmentation. Recently, Chenini et al. (2019) described for
a group of restless legs patients that the leg movement arousals
were better associated with the presence of non-dipping BP
than the restless legs index by itself. This study emphasizes that
arousals induced by sleep-related respiratory or movement events
are important for the investigation of non-dipping BP.
Interestingly, sleep efficiency had no impact at all in our
model of the HP analysis. There is some evidence that both
short sleep duration and insomnia might decrease cardiovascular
health especially due to AHT (Anttalainen et al., 2018; Jarrin et al.,
2018). However, our protocol only analyzed the percentage of
wakefulness in the first 20 min of sleep. It is possible that the
investigated period was too short to cause any important effect
on the nocturnal HP.
There are some limitations in our study. First, the study
population is relatively small. However, most of the studies
using the beat-to-beat measurement technique and those cited
above included a substantial smaller number of participants
than ours. At present, only ABPM studies manage recruitments
of large cohorts to investigate the relationship between OSA
and nocturnal BP. Another possible confounding factor consists
in the fact that the inflated cuff of the Nexfin/HD monitor
could be responsible for sleep fragmentation. This might be
particularly true in patients with a low arousal threshold, which
are more commonly found in the control group. However, we
cannot exclude the possibility that discomfort increased the BP
or induced the artificial sleep fragmentation. The overall HP
development in the control group is not in accordance to this
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hypothesis. The volume clamp method has been successfully
tested in several sleep studies, and in our experience, the
complaints about the cuff pressure started after a measurement
period exceeding the one used in this study protocol. The
definition of OSA in this study was an AHI of ≥15/h. We
cannot rule out that in the control group, there exists a
clinically relevant OSA with an AHI between 5 and 15 events/h
sleep. Nevertheless, the aim of this study was to investigate
which parameters influence the development of the HP at
sleep onset, not OSA as a disease. Therefore, like in other
studies, the criterion C of the international classification of sleep
disorders was applied (American Academy of Medicine,, 2014;
Genta-Pereira et al., 2018).
CONCLUSION
In this study, we investigated in patients with OSA the evolution
of three HPs: SBP, SV, and HR during sleep onset. In the OSA
group, both SBP and SV increased during sleep resulting in
a significant distinction compared to the control group. This
finding reached a moderate to high effect size confirming the
relevance of the results. HP short-term variation of the three
parameters was significantly higher in OSA patients with either
a large (SBP and SV) or very large (HR) effect size. In the
ROC curve analysis, nocturnal SBP and wake–sleep BP difference
demonstrated a higher AUC for sleep fragmentation than for
OSA. Analysis of the HP evolution at sleep onset by means of
the standardized correlation coefficient β (SCB) confirmed an
opposed evolution pattern between controls and OSA patients
with increasing SBP and SV in the latter group. The AI as
a marker of sleep fragmentation was identified as the major
contributor for HP evolution and the development of the non-
dipping pattern of the SBP in OSA patients.
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